Current Evidence for Circulating Tumor DNA in Sarcoma: Challenges and Opportunities for Clinical Application - Top-Institutions - MDSpire

Emerging Insights on Circulating Tumor DNA in Sarcoma: Navigating Clinical Challenges and Potential Applications

  • By

  • Kristin E. Goodsell

  • Jason A. Carter

  • Hannah R. Abrams

  • Harveshp Mogal

  • Elizabeth T. Loggers

  • Jeremy Sharib

  • July 12, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Oncology

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology

  • #3

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Oncology

  • #4

    Fred Hutch Cancer Center
    Fred Hutch Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

Original Source(s)

Current Evidence for Circulating Tumor DNA in Sarcoma: Challenges and Opportunities for Clinical Application

  • by Kristin E. Goodsell, Jason A. Carter, Hannah R. Abrams, Harveshp Mogal, Elizabeth T. Loggers, Jeremy Sharib

  • July 12, 2026

Related Content

A machine learning-based prognostic model for de novo metastatic HR-positive breast cancer: SEER cohort with external validation

Efficacy and safety analysis of immune checkpoint inhibitors combined with chemotherapy in the treatment of advanced triple-negative breast cancer: an umbrella meta-analysis

Multitask learning for early treatment response and survival prediction in lung cancer radiotherapy using sequential CBCT imaging